Source: Investing.com ↗

Oppenheimer raises Pharvaris stock price target on trial results

|

Translation unavailable. Please try again.

Original report

Read the original report on Investing.com ↗

Recommended markets

No specific asset was identified in this report; browse live USDT reference pairs.

Browse markets →

USDC/USDT

$1.00

-0.03%

BTC/USDT

$85,888.00

+0.08%

ETH/USDT

$2,735.91

-0.20%

ZEC/USDT

$1,623.84

+7.68%

XRP/USDT

$1.59

+4.05%